Latest filing published 13 Jun 2024 for 10x Genomics, Inc..
Filing timeline
BuySaleInsider track record
Mathai Mammen: trading record in brief
Mathai Mammen, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Innoviva, Inc., Theravance Biopharma, Inc. and 10x Genomics, Inc. We count 81 filings; the first trade dates from 29 January 2008 and the latest from 11 June 2024.
Every open-market trade on record is a sale: 13 sales worth €3.8M. Other entries cover 52 share grants and 14 option exercises.
The latest filing, published on 13 June 2024, reports a share grant in 10x Genomics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mathai Mammen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,649 shares0Class A Common StockSEC:0001610717-24-000326:0
- 1,865 shares0Class A Common StockSEC:0001610717-23-000173:0
- 33,000 shares@ US$52.8288.3% of flowClass A Common StockSEC:0001610717-23-000035:1
- 200,000 shares@ US$1.16100.0% of flowClass A Common StockSEC:0001610717-23-000035:0
- 2,120 shares0Class A Common StockSEC:0001567619-22-013119:0
- 3,366 shares@ US$165.8958.7% of flowCommon StockSEC:0001225208-22-002372:1
- 7,740 shares0Common StockSEC:0001225208-22-002372:0
- 2,335 shares@ US$168.8541.3% of flowCommon StockSEC:0001225208-22-002220:1
- 7,418 shares0Common StockSEC:0001225208-22-002220:0
- 625 shares0Class A Common StockSEC:0001209191-21-040689:0
- 90,000 shares0Ordinary SharesSEC:0001179110-16-021854:0
- 19,844 shares@ US$15.65100.0% of flowOrdinary SharesSEC:0001179110-16-019964:0
- 934 shares@ US$12.98Ordinary SharesSEC:0001179110-15-012565:0
- 130,000 shares0Ordinary SharesSEC:0001179110-15-002175:0
- 658 shares0Common StockSEC:0001179110-14-017016:0
- 3,261 shares@ US$22.76Common StockSEC:0001179110-14-013189:0
- 28,365 shares0Common StockSEC:0001179110-14-010617:0
- 50,000 shares0Common StockSEC:0001179110-14-009786:0
- 21,000 shares0Common StockSEC:0001179110-14-009786:1
- 22,833 shares@ US$26.86Common StockSEC:0001179110-14-008230:0
- 1,200 shares0Common StockSEC:0001179110-14-008230:1
- 37,500 shares0Common StockSEC:0001179110-14-007351:0
- 12,903 shares@ US$12.40Common StockSEC:0001179110-14-004925:0
- 29,250 shares@ US$16.00Common StockSEC:0001179110-14-004925:1
- 4,307 shares@ US$39.98Common StockSEC:0001179110-14-003523:0
25 of 74 declarations
